Overview / Abstract: |
Although the most common of the restrictive lung diseases, idiopathic pulmonary fibrosis (IPF) is a rare but deadly disease, affecting an estimated 6.8 to 42.7 per 100,000 people, with higher rates in those older than 65 years, and resulting in approximately 40,000 deaths annually in the United States. Education to community pulmonologists, radiologists, and primary care physicians, as well as the multidisciplinary team is important to increase knowledge related to recognition and diagnosis. Clinicians need to be aware of when to refer patients with potential IPF to specialty centers with pulmonologists, radiologists, and pathologists specialized in interstitial lung disease (ILD). All providers in the multidisciplinary and multispecialty treatment team need education related to recent ATS/ERS/JRS/ALAT guidelines and mechanisms of action for the approved treatments for IPF. On January 18, 2017, a CME Outfitters Live and On Demand featured a discussion of baseline data of self-reported gaps in care and skills in recognition, referral, and treatment of IPF. To meet the learning preferences of busy clinicians, the activity has been divided into three short modules. |
Expiration |
Mar 02, 2018 |
Discipline(s) |
Athletic Trainer , Clinical Laboratory CE, EMS / EMT / Paramedic CE, Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physical Therapy CE, Physician CME, Physician Assistant CME, Respiratory Therapy CE |
Format |
Online, Performance Improvement, Podcast, Webinar / Webcast / Video |
Credits / Hours |
.5 |
Accreditation |
ACCME, AANP, ACPE, AAPA |
Presenters / Authors / Faculty |
Steven D. Nathan, MD, FCCP A. Whitney Brown, MD Jonathan H. Chung, MD |
Sponsors / Supporters / Grant Providers |
Boehringer Ingelheim Pharmaceuticals, Inc.; Genentech. |
Keywords / Search Terms |
CME Outfitters, LLC IPF, Lung disease, ILD, pulmonary, pulmonary fibrosis, pulmonologist, pulmonology, interstitial lung disease, idiopathic pulmonary fibrosis, lung Free CE CME |